Drug product company Hovione announced on Monday that it has appointed Jean-Luc Herbeaux as its chief operating officer (COO), to be based in Lisbon, Portugal.
Effective 1 May 2020, Dr Herbeaux will work with the company's chief executive officer Guy Villax in executing its strategy and vision.
Most recently, Dr Herbeaux has served as head of the Health Care Business Line of Evonik, where he repositioned the business by driving an intentional, sustainable and profitable growth agenda.
Dr Herbeaux brings to the company a proven commitment to develop a successful and globally active business, it added.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer